Liposomal vitamin C vs regular vitamin C
Last updated:
Liposomal vitamin C is ascorbic acid or a mineral ascorbate enclosed in phospholipid vesicles1. In a 2025 scoping review, 9 of 10 small human studies found higher blood levels than with regular vitamin C: 1.2 to 5.4 times the peak and 1.3 to 7.2 times the total exposure1. No study measured urinary loss, and the two that tested biological effects found little difference1.
What is the difference between liposomal and regular vitamin C?
Vitamin C (L-ascorbic acid) is an essential nutrient for people because humans lost the enzyme L-gulonolactone oxidase, the last step in the pathway most other animals use to make it1. Regular supplements contain ascorbic acid or its sodium salt, sodium ascorbate, and natural and synthetic L-ascorbic acid are chemically identical, with no known differences in biological activity or bioavailability2.
In a liposomal product, the vitamin is encapsulated within lipid vesicles made of natural or synthetic phospholipids, with or without other components, and the vesicles range from about 20 nanometers to more than 1 micrometer across1. Regulators define a liposome as one or more bilayers of amphipathic molecules such as phospholipids enclosing a central water compartment, where water-soluble compounds like vitamin C are held6. The same guidance separates liposomes from emulsions, microemulsions and drug-lipid complexes, which are different structures6.
The two forms are thought to enter the body differently. Regular vitamin C is absorbed through a sodium-dependent transporter in the intestine called SVCT1, while liposomes are absorbed through SVCT-independent mechanisms such as endocytosis1.
Why does the body limit how much regular vitamin C it absorbs?
Blood vitamin C is tightly controlled by three mechanisms: intestinal absorption, transport into tissues and reabsorption in the kidney2. Pharmacokinetic studies summarized by the Linus Pauling Institute at Oregon State University found close to complete absorption when single amounts are small, with a steadily smaller fraction absorbed as single amounts grow larger2. Once plasma is saturated, extra vitamin C is largely excreted in urine2.
Liposomal formulas are designed to raise bioavailability by using absorption routes that do not depend on this transporter1. Intravenous vitamin C bypasses intestinal control entirely and reaches far higher plasma concentrations, which the kidneys bring back to baseline within a few hours2.
How much more vitamin C does the liposomal form deliver?
The most complete summary is a 2025 scoping review from the University of Otago, which screened 321 records and kept 10 human studies that compared liposomal with non-liposomal vitamin C1. Nine of the 10 reported higher plasma bioavailability for the liposomal form1. Every included study had industry funding, authors employed by companies, or both1.
The largest trial in the review gave 27 adults a single serving of liposomal vitamin C, standard vitamin C or placebo in a double-blind crossover design4. Compared with standard vitamin C, the liposomal form raised peak concentration by 27% in plasma and 20% in white blood cells, and total exposure over 24 hours by 21% and 8%4. The ingredient supplier funded that trial4.
| Study | Design | Participants | Plasma exposure (AUC), liposomal vs regular |
|---|---|---|---|
| Purpura et al., 2024 | Randomized crossover | 27 adults | 1.3 times |
| Zmuda et al., 2024 | Randomized crossover | 10 adults | 1.3 times |
| McGarry et al., 2024 | Randomized crossover | 12 adults | Not reported; small but significant rise |
| Wen et al., 2022 | Non-randomized | 11 adults | 2.3 times |
| Joseph et al., 2021 | Randomized crossover | 14 adults | 7.2 times |
| Jacob et al., 2021 | Randomized crossover | 8 men | 5.9 times |
| Gopi and Balakrishnan, 2021 | Randomized crossover | 24 adults | 1.8 times |
| Lukawski et al., 2020 | Parallel group | 20 adults | 1.8 times |
| Mikirova et al., 2019 | Non-randomized | 5 adults | 1.03 times (no significant difference) |
| Davis et al., 2016 | Randomized crossover | 11 adults | 1.4 times |
Why do the results vary so much between studies?
The studies used very different liposomal formulations, amounts and sampling windows of 4 to 24 hours, which makes direct comparison difficult1. Baseline vitamin C status matters most. When people start with low levels, their tissues pull vitamin C out of the blood, so regular vitamin C produces little plasma peak and the liposomal form can look several times better1. In the two trials whose participants started below adequate status, liposomal exposure was six to seven times higher, while trials in people with adequate status found differences of only 1.3 to 1.4 times1.
Three gaps limit what the numbers mean. None of the studies measured how much vitamin C left in urine, so a higher blood level may simply be followed by higher excretion1. Only two measured uptake into cells1. Several sampled blood for just 4 to 6 hours, too short to describe clearance1.
Digestion is a further variable. Conventional liposomes are damaged by stomach acid, bile salts and pancreatic lipases, which leads to leakage of their contents, and only vesicles that survive digestion can be absorbed intact through M cells, which make up about 1% of intestinal lining cells5.
Does liposomal vitamin C have more benefits?
Higher blood levels have not yet translated into measured benefits1. Only two studies tested biological effects, and both found small or no differences1. In a 2016 randomized crossover study at Colorado State University, 11 adults received the same amount of vitamin C as regular oral, liposomal oral and intravenous preparations3. Liposomal vitamin C produced blood levels higher than regular oral but lower than intravenous, and all three gave similar protection against oxidative stress after a forearm blood-flow test3.
In a 2024 crossover trial in 12 adults, the liposomal form gave about 5% more antioxidant capacity in serum at 2 hours, but no added protection of cells or nucleic acids from oxidative damage1. The review judged the clinical significance of these small differences uncertain and likely minimal1. Whether liposomal vitamin C improves any health outcome remains untested1.
What is the difference between liposomal and buffered vitamin C?
Buffered vitamin C means mineral salts of ascorbic acid, mainly sodium ascorbate and calcium ascorbate, which are less acidic and which some people find less irritating to the digestive tract2. They also add a mineral: sodium ascorbate is about 11% sodium by weight, and calcium ascorbate about 9% to 11% calcium2. Buffering is about acidity and stomach comfort, and it is independent of encapsulation: several liposomal trials encapsulated sodium or calcium ascorbate rather than ascorbic acid1,2.
| Form | What it is | Absorption evidence |
|---|---|---|
| Ascorbic acid | Plain L-ascorbic acid, natural or synthetic | Natural and synthetic forms show no known difference in bioavailability2 |
| Buffered (mineral ascorbates) | Sodium, calcium or other mineral salts | Less acidic; some people find them gentler on the digestive tract2 |
| Vitamin C with flavonoids | Ascorbic acid blended with plant pigments | Little evidence that added flavonoids raise bioavailability2 |
| Calcium ascorbate with metabolites | Mainly calcium ascorbate plus small amounts of vitamin C metabolites | An early study found no difference in absorption or urinary excretion versus standard tablets2 |
| Ascorbyl palmitate | Vitamin C bonded to palmitic acid, fat soluble | Mostly split back into ascorbic acid and palmitic acid in the gut before absorption2 |
| Liposomal | Ascorbic acid or a mineral ascorbate inside phospholipid vesicles | Higher plasma levels in 9 of 10 small, industry-linked studies1 |
Key takeaways
- Liposomal vitamin C encloses ascorbic acid or a mineral ascorbate in phospholipid vesicles that are absorbed by routes other than the intestinal vitamin C transporter.
- In 9 of 10 small human studies, liposomal vitamin C produced higher blood levels, from 1.3 to 7.2 times the total exposure, and all 10 studies had industry links.
- The largest gains appeared in people who started with low vitamin C status; in people with adequate status the difference was about 1.3 to 1.4 times.
- No study has measured urinary loss, and the two that tested biological effects found small or no differences.
- Buffered vitamin C is a less acidic mineral salt form, and it can itself be encapsulated in liposomes.
References
- Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions
- Vitamin C (Micronutrient Information Center)
- Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury
- Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial
- Adapting liposomes for oral drug delivery
- Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation. Guidance for Industry
Frequently asked questions
Does liposomal vitamin C reach the levels of intravenous vitamin C?
Why does starting vitamin C status change the results?
People with low status absorb vitamin C into their tissues quickly, so regular vitamin C shows little peak in plasma1. That can exaggerate the apparent advantage of a liposomal form, which is why the review recommends that future trials measure urinary excretion, cell uptake and repletion over time1.
How can you tell whether a liposomal product contains real liposomes?
For liposomal drugs, FDA guidance asks manufacturers to specify mean particle size and size distribution, the share of drug inside versus outside the liposomes, and lipid breakdown products such as lysolipids6. Products described as liposomal in vitamin C trials ranged from phospholipid dispersions to lecithin blends with gums and polysaccharides1. Asking a supplier for the same measurements is the most direct check.
Do liposomal vitamin C products stay stable on the shelf?
Liposomes are chemically vulnerable: lipids with unsaturated fatty acids oxidize, and both saturated and unsaturated lipids can break down by hydrolysis into lysolipids and free fatty acids6. FDA guidance for liposomal drugs therefore asks for stability testing of vesicle size distribution and integrity over shelf life6.